Stock Events

Stock Events

Revolution Medicines 

$207.32
117
-$2.70-1.29% Tuesday 20:00
+$1.38+0.67%Tuesday 23:52After hours

Statistics

Day High
207.49
Day Low
207.05
52W High
224.31
52W Low
39.73
Volume
54,161
Avg. Volume
-
Mkt Cap
44.44B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

11NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-3.06
-2.37
-1.68
-0.99
Expected EPS
-2.430901
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-1.13BNet Income

Analyst Ratings

226.31Average Price Target
The highest estimate is 320.00.
From 16 ratings within the last 6 months. This is not an investment recommendation.
Buy
94%
Hold
6%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RVMD. It's not an investment recommendation.
NVIDIA
31
NVDA
Apple
29
AAPL
Amazon
27
AMZN
Microsoft
26
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap236.38B
Amgen is a biotech giant that competes in the oncology space, developing treatments that could directly compete with Revolution Medicines' cancer therapies.
Bristol-Myers Squibb
BMY
Mkt Cap136.49B
Bristol Myers Squibb is involved in discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases, including cancer, which puts it in direct competition with Revolution Medicines.
Merck
MRK
Mkt Cap370.89B
Merck is a global healthcare company that produces cancer drugs and therapies, competing with Revolution Medicines in the oncology market.
Gilead Sciences
GILD
Mkt Cap187.23B
Gilead Sciences is a biopharmaceutical company that develops and markets therapies in areas including oncology, competing with Revolution Medicines' cancer treatment portfolio.
Pfizer
PFE
Mkt Cap162.16B
Pfizer is a global pharmaceutical corporation with a broad range of oncology products, competing with Revolution Medicines in the cancer treatment space.
Novartis
NVS
Mkt Cap304.1B
Novartis is a global healthcare company that has a strong focus on pharmaceuticals and biotechnology, including oncology, making it a competitor to Revolution Medicines.
Abbvie
ABBV
Mkt Cap453.19B
AbbVie is a pharmaceutical company that engages in the discovery, development, manufacture, and sale of a broad line of healthcare products including oncology, competing with Revolution Medicines.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG is a healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its extensive work in oncology competes with Revolution Medicines.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca is a global, science-led biopharmaceutical business that focuses on the discovery, development, and commercialization of prescription medicines, including for cancer, competing with Revolution Medicines.
Regeneron Pharmaceuticals
REGN
Mkt Cap85.22B
Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions, including cancer, competing with Revolution Medicines.

About

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
Show more...
CEO
Mark A. Goldsmith
Employees
883
Country
United States
ISIN
US76155X1000
WKN
000A2PYWG

Listings

MI
IT
1RVMD.MI
XETRA
DE
42Z.XETRA
STU
DE
42Z.STU
MU
DE
42Z.MU

0 Comments

Share your thoughts

FAQ

What is Revolution Medicines stock price today?▼
The current price of RVMD is $207.32 USD — it has decreased by -1.29% in the past 24 hours. Watch Revolution Medicines stock price performance more closely on the chart.
What is Revolution Medicines stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Revolution Medicines stocks are traded under the ticker RVMD.
Is Revolution Medicines stock price growing?▼
RVMD stock has fallen by -0.91% compared to the previous week, the month change is a +1.06% rise, over the last year Revolution Medicines has showed a +406.4% increase.
What is Revolution Medicines market cap?▼
Today Revolution Medicines has the market capitalization of 44.44B
When is the next Revolution Medicines earnings date?▼
Revolution Medicines is going to release the next earnings report on November 11, 2026.
What were Revolution Medicines earnings last quarter?▼
RVMD earnings for the last quarter are -3.06 USD per share, whereas the estimation was -2.04 USD resulting in a -49.81% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Revolution Medicines revenue for the last year?▼
Revolution Medicines revenue for the last year amounts to 0 USD.
What is Revolution Medicines net income for the last year?▼
RVMD net income for the last year is -1.13B USD.
How many employees does Revolution Medicines have?▼
As of September 09, 2026, the company has 883 employees.
In which sector is Revolution Medicines located?▼
Revolution Medicines operates in the Health & Wellness sector.
When did Revolution Medicines complete a stock split?▼
Revolution Medicines has not had any recent stock splits.
Where is Revolution Medicines headquartered?▼
Revolution Medicines is headquartered in REDWOOD CITY, United States.